<DOC>
	<DOCNO>NCT01293994</DOCNO>
	<brief_summary>The investigator collect saliva DNA sample chronic back pain patient . The investigator hope find candidate gene associate response opioid medication correlate molecular genetics data pain measurement opioid responsiveness data include opioid hyperalgesia opioid analgesic tolerance .</brief_summary>
	<brief_title>A Study Genetic Variation Influencing Pain Response Opioid Medications</brief_title>
	<detailed_description>The investigator hope find genetic association various physiologic response opioid medication patient suffer chronic pain ( e.g . OIH vs. analgesic tolerance , baseline pain sensitivity , etc. ) . This never do , prove successful , could provide physician great understand chronic opioid user continue need increase dos opioids . This data may also help predict patient well chronic opioid therapy one may . Initial data OPRM1 gene analysis human already implicate certain SNPs opioid responsiveness suggestion screen patient OPRM1 prior initiate opioid therapy order optimize treatment response ( Reynolds et al. , 2008 ) . Clin Lab Med . 2008 Dec ; 28 ( 4 ) :581-98 . The value CYP2D6 OPRM1 pharmacogenetic test opioid therapy . Reynolds KK , Ramey-Hartung B , Jortani SA .</detailed_description>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>1 . Adult patient , age 1871 2 . Recipient chronic opioid therapy 3 . Patient able produce saliva sample 4 . If past study participant , patient agree contacted future study . a. meeting inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>71 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Pain , Genetic Variation , Opioid Medications , Pain</keyword>
</DOC>